Immunohistochemical analysis of transforming growth factor β in gallbladder cancer

Oncology Reports

Volumn 10, Issue 2, 2003, Pages 327-332

  Kitamura, Keiichi ^a   Kasuya, Kazuhiko ^a   Tsuchida, Akihiko ^a   Mimuro, Akihiro ^a   Inoue, Keiichiro ^a   Aoki, Toshiaki ^a   Aoki, Tatsuya ^a   Koyanagi, Yasuhisa ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Angiogenesis; Gallbladder cancer; Transforming growth factor

Indexed keywords

CD34 ANTIGEN; CELL SURFACE RECEPTOR; ENG PROTEIN, HUMAN; KI 67 ANTIGEN; LEUKOCYTE ANTIGEN; TRANSFORMING GROWTH FACTOR BETA; VASCULAR CELL ADHESION MOLECULE 1;

AGED; ARTICLE; COMPARATIVE STUDY; ENZYME IMMUNOASSAY; FEMALE; GALLBLADDER TUMOR; HUMAN; MALE; METABOLISM; MICROCIRCULATION; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PROGNOSIS; TUMOR ASSOCIATED LEUKOCYTE; VASCULARIZATION;

AGED; ANTIGENS, CD; ANTIGENS, CD34; FEMALE; GALLBLADDER NEOPLASMS; HUMANS; IMMUNOENZYME TECHNIQUES; KI-67 ANTIGEN; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MICROCIRCULATION; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; RECEPTORS, CELL SURFACE; TRANSFORMING GROWTH FACTOR BETA; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0038148430     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.10.2.327     Document Type: Article

References (30)

1. cdc2phosphorylation and histone H1 kinase activity is associated with G1/S-phase growth arrest. Mol Cell Biol 11: 1185-1194, 1991.
2. Koff A, Ohtsuki M, Polyak K, Roberts JM and Massague J: Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-β. Science 260: 536-539, 1993. (Pubitemid 23161617)
3. Laiho M, De Caprio JA, Ludlow JW, Livingston DM and Massague J: Growth inhibition by TGF-β linked to suppression of retionoblastoma protein phosphorylation. Cell 62: 175-185, 1990.
4. Roberts AB and Sporn MB: The transforming growth factors-beta. In: Handbook of Experimental Pharmacology; Peptide Growth Factors and their Receptors. Sporn MB and Roberts AB (eds). Springer Verlag, Berlin, pp419-472, 1990.
5. Ravitz MJ and Wenner CE: Cyclin-dependent kinase regulation during G1 phase and cell cycle regulation by TGF-beta. Adv Cancer Res 71: 165-207, 1997.
6. Markowits SD and Roberts AB: Tumor suppressor activity of the TGF-beta pathway in human cancers. Cytokine Growth Factor Rev 7: 93-102, 1996.
7. Taipale J, Saharinen J and Kenski-Oja J: Extracellular matrix-associated transforming growth factor-beta: role in cancer cell growth and invasion. Adv Cancer Res 75: 87-134, 1998. (Pubitemid 28429034)
8. Gohongi T, Boucher Y, Yun CO, Soff GA, Compton C, Todoroki T and Jain RK: Tumor-host interactions in the gallbladder suppress distal angiogenesis and tumor growth: involvement of transforming growth factor β1. Nat Med 5: 1203-1208, 1999. (Pubitemid 29474428)
9. Yukawa M, Fujimori T, Hirayama D, Idei Y, Ajiki T, Kawai K, Sugiura R, Maeda A and Nagasako K: Expression of oncogene products and growth factors in early gallbladder cancer, advanced gallbladder cancer, and chronic cholecystitis. Hum Pathol 24: 37-40, 1993. (Pubitemid 23046670)
10. Su WC, Shiesh SC, Liu HS, Chen CY, Chow NH and Lin XZ: Expression of oncogene products HER2/Neu and Ras and fibrosis-related growth factors bFGF, TGF-beta, and PDGF in bile from biliary malignancies and inflammatory disorders. Dig Dis Sci 46: 1387-1392, 2001.
11. Miyazono K, Olofsson A, Colosetti P and Heldin CH: A role of the latent TGF-beta 1-binding protein in the assembly and secretion of TGF-beta 1. EMBO J 10: 1091-1101, 1991. (Pubitemid 21905570)
12. Mizoi T, Ohtani H, Miyazono K, Miyazawa M, Matsuno S and Nagura H: Immunoelectron microscopic localization of transforming growth factor β1 and latent transforming growth factor β1 binding protein in human gastrointestinal carcinomas: qualitative difference between cancer cells and stromal cells. Cancer Res 53: 183-190, 1993. (Pubitemid 23019396)
13. Yoshida K, Yokozaki H, Niimoto M, Ito H, Ito M and Tahara E: Expression of TGF-beta and procollagen type I and type III in human gastric carcinomas. Int J Cancer 44: 394-398, 1989. (Pubitemid 19229293)
14. Oft M, Peli J, Rudaz C, Schwarz H, Beug H and Reichmann E: TGF-β1 and H-ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells. Genes Dev 10: 2462-2477, 1996. (Pubitemid 26341881)
15. Piek E, Moustakas A, Kurisaki A, Heldin CH and Ten Dijke P: TGF-beta type I receptor/ALK-5 and Smad proteins mediate epithelial to mesenchymal transdifferentiation in NMuMG breast epithelial cells. J Cell Sci 112: 4557-4568, 1999. (Pubitemid 30034805)
16. Stearns ME, Garcia FU, Fudge K, Rhim J and Wang M: Role of interluekin 10 and transforming growth factor β1 in the angiogenesis and metastasis of human prostate primary tumor lines from orthotopic implants in severe combined immunodeficiency mice. Clin Cancer Res 5: 711-720, 1999. (Pubitemid 29131984)
17. Ye SC, Foster JM, Li W, Liang J, Zborowska E, Venkateswarlu S, Gong J, Brattain MG and Willson KV: Contextual effects of transforming growth factor β on the tumorigenicity of human colon carcinoma cells. Cancer Res 59: 4725-4731, 1999. (Pubitemid 29428983)
18. Blobe GC, Schiemann WP and Lodish HF: Role of transforming growth factor beta in human disease. N Engl J Med 342: 1350-1358, 2000. (Pubitemid 30408720)
19. Markowitz S, Wang J, Myeroff L, Parsons R, Sun L, Lutterbaugh J, Fan RS, Zborowska E, Kinzler KW and Vogelstein B: Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science 268: 1336-1338, 1995.
20. Reiss M: TGF-β and cancer. Microbes Infect 1: 1327-1347, 1999.
21. Pepper MS: Transforming growth factor-beta: vasculogenesis, angiogenesis, and vessel wall integrity. Cytokine Growth Factor Rev 8: 21-43, 1997.
22. Wang JM, Kumar S, Pye D, Haboubi N and Al-Nakib L: Breast carcinoma: comparative study of tumor vasculature using two endothelial cell markers. J Natl Cancer Inst 86: 386-388, 1994. (Pubitemid 24076881)
23. Kumar S, Ghellal A, Li C, Byrne G. Haboubi N, Wang JM and Bundred N: Breast carcinoma: vascular density determined using CD105 antibody correlates with tumor prognosis. Cancer Res 59: 856-861, 1999. (Pubitemid 29086739)
24. Tada T, Ohzeki S, Utsumi K, Takiuchi H, Muramatsu M, Li XF, Shimizu J, Fujiwara H and Hamaoka T: Transforming growth factor-beta-induced inhibition of T cell function. Susceptibility difference in T cells of various phenotypes and functions and its relevance to immunosuppression in the tumor-bearing state. J Immunol 146: 1077-1082, 1991.
25. Walker RA, Dearing SJ and Gallacher B: Reationship of transforming growth factor β1 to extracellular matrix and stromal infiltrates in invasive breast carcinoma. Br J Cancer 69: 1160-1165, 1994. (Pubitemid 24161880)
26. Hildenbrand R, Jansen C, Wolf G, Bohme B, Berger S, von Minckwitz G, Horlin A, Kaufmann M and Stutte HJ: Transforming growth factor-β stimulates urokinase expression in tumor-associated macrophages of the breast. Lab Invest 78: 59-71, 1998. (Pubitemid 28074309)
27. Hildenbrand R, Dilger I, Horlin A and Stutte HJ: Urokinase and macrophages in tumour angiogenesis. Br J Cancer 72: 818-823, 1995.
28. Wahl SM, Allen JB, Weeks BS, Wong HL and Klotman PE: Transforming growth factor beta enhances integrin expression and type IV collagenase secretion in human monocytes. Proc Natl Acad Sci USA 90: 4577-4581, 1993. (Pubitemid 23148948)
29. Noble PW, Henson PM, Lucas C, Mora-Worms M, Carre PC and Riches DW: Transforming growth factor-beta primes macrophages to express inflammatory gene products in response to particulate stimuli by an autocrine/paracrine mechanism. J Immunol 151: 979-989, 1993. (Pubitemid 23215764)
30. Kobayashi S, Nagaura T, Kimura I and Kimura M: Interferon-gamma-activated macrophages enhance angiogenesis from endothelial cells of rat aorta. Immunopharmacology 27: 23-30, 1994.